Objective: To investigate the safety of peri-operative management on children with juvenile recurrent respiratory papilloma (JORRP).
Methods: A retrospective analysis was conducted on preoperative assessment, anesthesia methods and options, operative procedure, and postoperative airway maintenance in 28 JORRP children aged from ten months to seven years old. A total of 148 times of surgery was performed on these 28 children.
Results: One hundred and nine JORRP children graded one and two-degree dyspnea underwent surgery within 24 hours and were intubated successfully in the first attempt after intravenous induction. Thirty-nine emergency operations were performed in the children graded three and four-degree dyspnea, 35 of them were intubated successfully in the first attempt after inhalation induction and 4 succeeded in the second attempt. No complications occurred in 129 JORRP children postoperatively, 17 children suffered from mild dyspnea and relieved after oxygen inhalation, 2 children were intubated and sent to intensive care unit because of postoperative hypoxemia. All JORRP children got through the peri-operative period safely. The quality of pronunciation in 101 children improved markedly and 35 suffered from slight hoarseness on the 1st postoperative day. Three children had the tracheal tube of tracheostomy removed after receiving five, four and three operations respectively. Nineteen children were followed up for 2 - 5 years. Among them, one child did not relapse 3 years after surgical management.One child suffered from laryngostenosis postoperatively. No death occurred.
Conclusion: Complete preoperative preparation, rational anesthesia methods, careful operative procedure and airway maintenance after surgery could increase the safety for children with recurrent respiratory papilloma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
HPV Vaccination in a Case of JORRP, a Variety of RRP in Bangladesh Medical College Hospital: A Case Report.
Mymensingh Med J
January 2025
Dr Sultana Jebunnaher, Associate Professor, Obstetrics and Gynaecology, Bangladesh Medical College and Hospital, Dhaka, Bangladesh; E-mail:
Recurrent respiratory papillomatosis (RRP) is a rare disease which is caused by human papilloma virus (HPV). It is a warty growth in the upper airway may cause significant airway obstruction or voice change. Though it is rare but one with severe morbidity and occasional mortality.
View Article and Find Full Text PDFTrends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review.
Acta Otolaryngol
January 2025
Department of Otorhinolaryngology, Head and Neck Surgery, and Audiology, Rigshospitalet, Copenhagen, Capital Region, Denmark.
Article Synopsis
- Infection with low-risk HPV types 6 and 11 can cause recurrent respiratory papillomatosis (JoRRP) in children, which leads to benign growths in the larynx.
- A systematic review studied the effects of national HPV vaccination programs on the incidence and prevalence of JoRRP, analyzing data from four studies that included 622 patients from countries like Australia, New Zealand, and the U.S.
- Results showed a significant decline in JoRRP cases after vaccination, with higher vaccination rates linking to lower disease burden, highlighting the importance of widespread HPV vaccination for future health outcomes.
Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
J Virol
October 2024
Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Article Synopsis
- Juvenile-onset recurrent respiratory papillomatosis (JORRP) is linked to low-risk HPV types 6 and 11, with CD8+ tissue-resident memory T cells playing a critical role in the immune response against this infection.
- Research revealed that CD8+ T cells producing interferon-gamma (IFN-γ) expanded in JORRP patients and their levels were inversely related to disease severity and surgical frequency.
- The study identified specific T cell receptor (TCR) clonotypes that could be targeted for potential TCR-engineered therapies, shedding light on the local immune dynamics in response to HPV6/11 infections.
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.
Viruses
August 2024
Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, NJ 07065, USA.
Article Synopsis
- Juvenile- and adult-onset recurrent respiratory papillomatosis (JORRP and AORRP) are rare and serious medical conditions caused by HPV, leading to growths in the throat and can even be deadly.
- The main treatment for these conditions is surgery, but getting vaccinated against HPV can help prevent infection.
- A new model shows that since the HPV vaccine was introduced in the US, it has saved many lives and reduced the number of cases significantly, with expected cases dropping to very low numbers by 2040.
Recurrent Laryngeal Papillomatosis in Denmark from 1994 to 2021: A Nationwide Register Study.
Laryngoscope
December 2024
Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Objectives: The aim of this study is to describe the incidence and demographics of laryngeal papillomatosis (LP) in Denmark, including sex and age distribution, recurrence rates, and HPV subtypes, using a new method of register identification.
Methods: The data were extracted from the Danish Pathology Data Bank using SNOMED codes instead of the usual method using ICD codes from the Danish National Health Register. The derived pathology records were manually verified by three medical doctors.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!